Animal models of kidney diseases

Source Book of Models for Biomedical Research

Volumn , Issue , 2008, Pages 657-664

  Dai, Chunsun ^a   Kiss, Lawrence P ^a   Liu, Youhua ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Acute renal failure; Chronic kidney disease; Diabetic nephropathy; Ischemia reperfusion; Remnant kidney; Renal fibrosis; Unilateral ureter obstruction

Indexed keywords

EID: 84885920950     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-285-4_68     Document Type: Chapter

References (68)

1. Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, Locatelli F, MacLeod A, Vanholder R, Walker R, Wang H. The burden of kidney disease: Improving global outcomes. Kidney Int 2004;66:1310-1314.
2. Middleton RJ, Foley RN, Hegarty J, Cheung CM, McElduff P, Gibson JM, Kalra PA, O'Donoghue DJ, New JP. The unrecognized prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant 2006;21:88-92.
3. White SL, Cass A, Atkins RC, Chadban SJ. Chronic kidney disease in the general population. Adv Chronic Kidney Dis 2005;12:5-13.
4. Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: Epidemiology, social, and economic implications. Kidney Int Suppl 2005;98:S7-S10.
5. Liu Y. Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney Int 2006;69:213-217.
6. Fogo AB. Progression versus regression of chronic kidney disease. Nephrol Dial Transplant 2006;21:281-284.
7. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998;339:1448-1456.
8. Hentschel DM, Bonventre JV. Novel non-rodent models of kidney disease. Curr Mol Med 2005;5:537-546.
9. Zoja C, Morigi M, Benigni A, Remuzzi G. Genetics of rare diseases of the kidney: Learning from mouse models. Cytogenet Genome Res 2004;105:479-484.
10. Zoja C, Abbate M, Remuzzi G. Progression of chronic kidney disease: Insights from animal models. Curr Opin Nephrol Hypertens 2006; 15:250-257.
11. Breyer MD, Bottinger E, Brosius FC 3rd, Coffman TM, Harris RC, Heilig CW, Sharma K. Mouse models of diabetic nephropathy. J Am Soc Nephrol 2005;16:27-45.
12. Bascands JL, Schanstra JP. Obstructive nephropathy: Insights from genetically engineered animals. Kidney Int 2005;68:925-937.
13. Zheng F, Striker GE, Esposito C, Lupia E, Striker LJ. Strain differences rather than hyperglycemia determine the severity of glomerulosclerosis in mice. Kidney Int 1998;54:1999-2007.
14. Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, Coffman TM. Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 2006;290:F214-222.
15. Wei Q, Wang MH, Dong Z. Differential gender differences in ischemic and nephrotoxic acute renal failure. Am J Nephrol 2005;25: 491-499.
16. Kher A, Meldrum KK, Wang M, Tsai BM, Pitcher JM, Meldrum DR. Cellular and molecular mechanisms of sex differences in renal ischemia-reperfusion injury. Cardiovasc Res 2005;67:594-603.
17. Abernethy VE, Lieberthal W. Acute renal failure in the critically ill patient. Crit Care Clin 2002;18:203-222.
18. Lieberthal W, Nigam SK. Acute renal failure. II. Experimental models of acute renal failure: Imperfect but indispensable. Am J Physiol Renal Physiol 2000;278:F1-F12.
19. Heyman SN, Lieberthal W, Rogiers P, Bonventre JV. Animal models of acute tubular necrosis. Curr Opin Crit Care 2002;8:526-534.
20. Mohaupt M, Kramer HJ. Acute ischemic renal failure: Review of experimental studies on pathophysiology and potential protective interventions. Renal Fail 1989;11:177-185.
21. Lieberthal W, Nigam SK. Acute renal failure. I. Relative importance of proximal vs. distal tubular injury. Am J Physiol Renal Physiol 1998;275:F623-631.
22. Safirstein RL. Acute renal failure: From renal physiology to the renal transcriptome. Kidney Int Suppl 2004;S62-S66.
23. Bonegio R, Lieberthal W. Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 2002;11:301-308.
24. Rana A, Sathyanarayana P, Lieberthal W. Role of apoptosis of renal tubular cells in acute renal failure: Therapeutic implications. Apoptosis 2001;6:83-102.
25. Wei Q, Yin XM, Wang MH, Dong Z. Bid deficiency ameliorates ischemic renal failure and delays animal death in C57BL/6 mice. Am J Physiol Renal Physiol 2006;290:F35-F42.
26. Fillastre JP, Raguenez-Viotte G. Cisplatin nephrotoxicity. Toxicol Lett 1989;46:163-175.
27. Schubert GE. Folic acid-induced acute renal failure in the rat: Morphological studies. Kidney Int Suppl 1976;6:S46-S50.
28. Liu Y, Tolbert EM, Lin L, Thursby MA, Sun AM, Nakamura T, Dworkin LD. Up-regulation of hepatocyte growth factor receptor: An amplifi cation and targeting mechanism for hepatocyte growth factor action in acute renal failure. Kidney Int 1999;55:442-453.
29. Dai C, Yang J, Liu Y. Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice. J Am Soc Nephrol 2002;13:411-422.
30. Ortega A, Ramila D, Izquierdo A, Gonzalez L, Barat A, Gazapo R, Bosch RJ, Esbrit P. Role of the renin-angiotensin system on the parathyroid hormone-related protein overexpression induced by nephrotoxic acute renal failure in the rat. J Am Soc Nephrol 2005;16:939-949.
31. Bledsoe G, Crickman S, Mao J, Xia CF, Murakami H, Chao L, Chao J. Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis. Nephrol Dial Transplant 2006;21:624-633.
32. Chander V, Chopra K. Protective effect of resveratrol, a polyphenolic phytoalexin on glycerol-induced acute renal failure in rat kidney. Renal Fail 2006;28:161-169.
33. Aydogdu N, Atmaca G, Yalcin O, Taskiran R, Tastekin E, Kaymak K. Protective effects of L-carnitine on myoglobinuric acute renal failure in rats. Clin Exp Pharmacol Physiol 2006;33:119-124.
34. Newaz M, Yousefipour Z, Oyekan A. Role of PPAR-gamma on the pathogenesis and vascular changes in glycerol-induced acute renal failure. Pharmacol Res 2006;54:234-240.
35. Langenberg C, Wan L, Egi M, May CN, Bellomo R. Renal blood fl ow in experimental septic acute renal failure. Kidney Int 2006;69: 1996-2002.
36. Wan L, Bellomo R, Di Giantomasso D, Ronco C. The pathogenesis of septic acute renal failure. Curr Opin Crit Care 2003;9:496-502.
37. Fu XJ, Iijima K, Nozu K, Hamahira K, Tanaka R, Oda T, Yoshikawa N, Matsuo M. Role of p38 MAP kinase pathway in a toxin-induced model of hemolytic uremic syndrome. Pediatr Nephrol 2004;19: 844-852.
38. Zager RA, Johnson AC, Lund S, Hanson SY, Abrass CK. Levosimendan protects against experimental endotoxemic acute renal failure. Am J Physiol Renal Physiol 2006;290:F1453-1462.
39. Susztak K, Bottinger EP. Diabetic nephropathy: A frontier for personalized medicine. J Am Soc Nephrol 2006;17:361-367.
40. Schena FP, Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 2005;16(Suppl. 1):S30-S33.
41. Breyer MD, Qi Z, Tchekneva E. Diabetic nephropathy: Leveraging mouse genetics. Curr Opin Nephrol Hypertens 2006;15:227-232.
42. Linden KC, DeHaan CL, Zhang Y, Glowacka S, Cox AJ, Kelly DJ, Rogers S. Renal expression and localization of the facilitative glucose transporters GLUT1 and GLUT12 in animal models of hypertension and diabetic nephropathy. Am J Physiol Renal Physiol 2006;290: F205-213.
43. O'Donnell MP, Kasiske BL, Keane WF. Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J 1988;2:2339-2347.
44. Matsubara T, Abe H, Arai H, Nagai K, Mima A, Kanamori H, Sumi E, Takahashi T, Matsuura M, Iehara N, Fukatsu A, Kita T, Doi T. Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy. Lab Invest 2006;86:357-368.
45. Zatz R, Meyer TW, Rennke HG, Brenner BM. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 1985;82:5963-5967.
46. Dai C, Yang J, Bastacky S, Xia J, Li Y, Liu Y. Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. J Am Soc Nephrol 2004;15:2637-2647.
47. Breyer MD, Bottinger E, Brosius FC, Coffman TM, Fogo A, Harris RC, Heilig CW, Sharma K. Diabetic nephropathy: Of mice and men. Adv Chronic Kidney Dis 2005;12:128-145.
48. Sharma K, McCue P, Dunn SR. Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 2003;284:F1138-1144.
49. Sugaru E, Nakagawa T, Ono-Kishino M, Nagamine J, Tokunaga T, Kitoh M, Hume WE, Nagata R, Taiji M. SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice. Am J Physiol Renal Physiol 2006;290:F813-820.
50. Park CW, Zhang Y, Zhang X, Wu J, Chen L, Cha DR, Su D, Hwang MT, Fan X, Davis L, Striker G, Zheng F, Breyer M, Guan Y. PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice. Kidney Int 2006;69:1511-1517.
51. Fleck C, Appenroth D, Jonas P, Koch M, Kundt G, Nizze H, Stein G. Suitability of 5/6 nephrectomy (5/6NX) for the induction of interstitial renal fibrosis in rats-influence of sex, strain, and surgical procedure. Exp Toxicol Pathol 2006;57:195-205.
52. Liu ZC, Chow KM, Chang TM. Evaluation of two protocols of uremic rat model: Partial nephrectomy and infarction. Renal Fail 2003;25:935-943.
53. Massy ZA, Ivanovski O, Nguyen-Khoa T, Angulo J, Szumilak D, Mothu N, Phan O, Daudon M, Lacour B, Drueke TB, Muntzel MS. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol 2005;16:109-116.
54. Al Banchaabouchi M, Marescau B, Van Marck E, D'Hooge R, De Deyn PP. Long-term effect of partial nephrectomy on biological parameters, kidney histology, and guanidino compound levels in mice. Metabolism 2001;50:1418-1425.
55. Chevalier RL. Pathophysiology of obstructive nephropathy in the newborn. Semin Nephrol 1998;18:585-593.
56. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofi broblast transition and its implications in renal interstitial fi brosis. Am J Pathol 2001;159:1465-1475.
57. Chevalier RL. Pathogenesis of renal injury in obstructive uropathy. Curr Opin Pediatr 2006;18:153-160.
58. Yang J, Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fi brosis. J Am Soc Nephrol 2002;13:96-107.
59. Yang J, Dai C, Liu Y. Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fi brosis in mice. J Am Soc Nephrol 2002;13:2464-2477.
60. Couser WG, Salant DJ, Stilmant MM, Arbeit LA, Darby C, Sliogeris VG. The effects of aminonucleoside of puromycin and nephrotoxic serum on subepithelial immune-deposit formation in passive Heymann nephritis. J Lab Clin Med 1979;94:917-932.
61. Wang Y, Wang YP, Tay YC, Harris DC. Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events. Kidney Int 2000;58:1797-1804.
62. Qin XH, Lee VW, Wang YP, Zheng GP, Wang Y, Alexander SI, Harris DC. A protective role for programmed death 1 in progression of murine adriamycin nephropathy. Kidney Int 2006;70(7):1244-1250.
63. Li C, Sun BK, Lim SW, Song JC, Kang SW, Kim YS, Kang DH, Cha JH, Kim J, Yang CW. Combined effects of losartan and pravastatin on interstitial inflammation and fibrosis in chronic cyclosporineinduced nephropathy. Transplantation 2005;79:1522-1529.
64. Khan M, Shobha JC, Mohan IK, Rao Naidu MU, Prayag A, Kutala VK. Spirulina attenuates cyclosporine-induced nephrotoxicity in rats. J Appl Toxicol 2006;26:444-451.
65. van Timmeren MM, Bakker SJ, Stegeman CA, Gans RO, van Goor H. Addition of oleic acid to delipidated bovine serum albumin aggravates renal damage in experimental protein-overload nephrosis. Nephrol Dial Transplant 2005;20:2349-2357.
66. van Timmeren MM, Bakker SJ, Vaidya VS, Bailly V, Schuurs TA, Damman J, Stegeman CA, Bonventre JV, van Goor H. Tubular kidney injury molecule-1 in protein-overload nephropathy. Am J Physiol Renal Physiol 2006;291:F456-464.
67. Ishola DA Jr, van der Giezen DM, Hahnel B, Goldschmeding R, Kriz W, Koomans HA, Joles JA. In mice, proteinuria and renal infl ammatory responses to albumin overload are strain-dependent. Nephrol Dial Transplant 2006;21:591-597.
68. Hentschel DM, Park KM, Cilenti L, Zervos AS, Drummond I, Bonventre JV. Acute renal failure in zebrafish: A novel system to study a complex disease. Am J Physiol Renal Physiol 2005;288: F923-929.